NYSE:NUS - Nu Skin Enterprises Stock Price, Forecast & News

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Nu Skin Enterprises announced a quarterly dividend on Wednesday, February 12th. Investors of record on Friday, February 28th will be paid a dividend of $0.375 per share on Wednesday, March 11th. This represents a $1.50 annualized dividend and a yield of 4.93%. The ex-dividend date is Thursday, February 27th. This is a boost from Nu Skin Enterprises's previous quarterly dividend of $0.37. View Nu Skin Enterprises' Dividend History.

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings data on Wednesday, February, 12th. The company reported $0.72 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.72. The business earned $583.36 million during the quarter, compared to analysts' expectations of $582.49 million. The company's revenue was down 14.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.05 earnings per share. View Nu Skin Enterprises' Earnings History.

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Nu Skin Enterprises.

Nu Skin Enterprises updated its FY20 earnings guidance on Wednesday, February, 12th. The company provided earnings per share (EPS) guidance of $2.00-2.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.31. The company issued revenue guidance of $2.17-2.30 billion, compared to the consensus revenue estimate of $2.47 billion.

7 Wall Street analysts have issued 1-year target prices for Nu Skin Enterprises' shares. Their forecasts range from $30.00 to $70.00. On average, they expect Nu Skin Enterprises' stock price to reach $44.71 in the next year. This suggests a possible upside of 46.8% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.

Media coverage about NUS stock has been trending somewhat positive this week, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nu Skin Enterprises earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Nu Skin Enterprises.

Nu Skin Enterprises saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 1,800,000 shares, an increase of 13.9% from the January 15th total of 1,580,000 shares. Based on an average daily trading volume, of 428,700 shares, the days-to-cover ratio is presently 4.2 days. Currently, 3.4% of the shares of the company are sold short. View Nu Skin Enterprises' Current Options Chain.

Some companies that are related to Nu Skin Enterprises include Avon Products (AVP), Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Inter Parfums (IPAR), Medifast (MED), Nature's Sunshine Products (NATR), Prestige Consumer Healthcare (PBH), Revlon (REV), USANA Health Sciences (USNA) and Veru (VERU).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Marathon Petroleum (MPC), Herbalife Nutrition (HLF), Baidu (BIDU), Alphabet (GOOG), Netflix (NFLX), Tesla (TSLA), Booking (BKNG) and Caterpillar (CAT).

Nu Skin Enterprises' stock is owned by a number of of retail and institutional investors. Top institutional investors include AQR Capital Management LLC (3.65%), Renaissance Technologies LLC (2.66%), State Street Corp (2.44%), Bank of New York Mellon Corp (1.65%), Goldman Sachs Group Inc. (1.35%) and Prudential Financial Inc. (0.95%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Foulis Greg, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

NUS stock was sold by a variety of institutional investors in the last quarter, including Martingale Asset Management L P, Cubist Systematic Strategies LLC, Acadian Asset Management LLC, Schroder Investment Management Group, Russell Investments Group Ltd., Los Angeles Capital Management & Equity Research Inc., Spark Investment Management LLC and Franklin Resources Inc.. View Insider Buying and Selling for Nu Skin Enterprises.

NUS stock was bought by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Bank of New York Mellon Corp, Bank of America Corp DE, Mackay Shields LLC, Goldman Sachs Group Inc., Panagora Asset Management Inc., UBS Group AG and MUFG Securities EMEA plc. View Insider Buying and Selling for Nu Skin Enterprises.

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NUS stock can currently be purchased for approximately $30.45.